ATP7B Gene: Copper Transport, Wilson Disease Spectrum, and Dietary Copper Accumulation

Copper is essential — involved in energy production, immune function, collagen synthesis, and neurotransmitter metabolism. But excess copper is toxic. The gene that keeps copper in balance is ATP7B, a copper-exporting ATPase in the liver. When it underperforms, copper accumulates. In its severest form this is Wilson disease. But the spectrum is wider than most people realize.

How ATP7B Works

The liver is the primary organ for copper homeostasis. ATP7B sits in hepatocytes and performs two functions: it incorporates copper into ceruloplasmin (the main copper-carrying protein in blood) and exports excess copper into bile for elimination. When dietary copper intake exceeds what the body needs, ATP7B ramps up export to prevent accumulation.

Variants that reduce ATP7B activity impair both functions. Ceruloplasmin levels may drop, reducing copper delivery to peripheral tissues. More critically, excess copper accumulates in hepatocytes — and eventually spills into the bloodstream, depositing in the brain, corneas, kidneys, and joints.

The Wilson Disease Spectrum

Classic Wilson disease involves two loss-of-function mutations in ATP7B (compound heterozygous or homozygous). It affects approximately 1 in 30,000 people and presents with liver disease, neurological symptoms (tremor, dysarthria, psychiatric disturbance), and Kayser-Fleischer rings in the cornea.

But heterozygous carriers — one functional copy, one reduced-function copy — are far more common (estimated 1 in 90 people). Classic teaching says carriers are unaffected. Emerging evidence suggests this may not be entirely accurate: heterozygous individuals show modestly elevated liver copper, lower ceruloplasmin, and may be more sensitive to high dietary copper intake over time.

For most heterozygous carriers the clinical impact is minimal. But in the context of a high-copper diet, significant alcohol use (which impairs copper handling), or additional genetic variants affecting copper metabolism, the cumulative effect may be more significant.

Copper in Food and Water

The richest dietary sources of copper are shellfish (especially oysters), liver, dark chocolate, nuts, seeds, and whole grains. Most people consume 0.9–2.2 mg per day — within the tolerable upper limit of 10 mg. But copper from drinking water (especially in homes with copper pipes) can add substantially to total intake without people realizing it.

For people with reduced ATP7B function, monitoring total copper exposure — dietary plus water — is a reasonable precaution. This does not mean avoiding all copper-containing foods, which also provide zinc, manganese, and other nutrients. It means awareness.